Prazosin: Difference between revisions
Brian Blank (talk | contribs) No edit summary |
Brian Blank (talk | contribs) No edit summary |
||
| Line 18: | Line 18: | ||
| routes_of_administration = Oral | | routes_of_administration = Oral | ||
}} | }} | ||
{{SI}} | |||
{{CMG}} | {{CMG}} | ||
{{Editor Join}} | {{Editor Join}} | ||
===[[Prazosin (patient information)|For patient information, click here]]=== | ===[[Prazosin (patient information)|For patient information, click here]]=== | ||
| Line 44: | Line 44: | ||
[[Category:Furans]] | [[Category:Furans]] | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
{{SIB}} | |||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Revision as of 15:41, 19 May 2009
 | |
| Clinical data | |
|---|---|
| Routes of administration | Oral |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Protein binding | 97% |
| Elimination half-life | 2–3 hours |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C19H21N5O4 |
| Molar mass | 383.401 g/mol |
|
WikiDoc Resources for Prazosin |
|
Articles |
|---|
|
Most recent articles on Prazosin |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Prazosin at Clinical Trials.gov Clinical Trials on Prazosin at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Prazosin
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Directions to Hospitals Treating Prazosin Risk calculators and risk factors for Prazosin
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Prazosin |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
For patient information, click here
Overview
Prazosin, trade names Minipress® and Hypovase®, is a medication used to treat high blood pressure (hypertension). It belongs to the class of alpha-adrenergic blockers, which lower blood pressure by relaxing blood vessels. Specifically, prazosin is selective for the alpha-1 receptors on vascular smooth muscle. These receptors are responsible for the vasoconstrictive action of norepinephrine, which in turn raises blood pressure. By blocking these receptors, prazosin reduces blood pressure.
Other features which add to the therapeutic value of Prazosin
1) The drug is orally active.
2) Unlike other less selective alpha blockers, which also block presynaptic alpha-2 receptors, it doesn't prevent inhibition of noradrenaline release. uninhibited noradrenaline release causes increased reflex tachycardia through the sympathetic baroreflex response that increases cardiac output, prazosin has a minimal effect on cardiac function due to its alpha-1 receptor selectivity.
3) Prazosin is also useful in treating urinary hesitancy associated with prostatic hyperplasia by blocking alpha-1 receptors, which control constriction of both the prostate and ureters.
Side effects of prazosin include orthostatic hypotension, syncope, and nasal congestion. The orthostatic hypotension and syncope are associated with the body's poor ability to control blood pressure without active alpha-adrenergic receptors. Patients on prazosin should be told not to stand up too quickly, since their poor baroreflex may cause them to faint as all their blood rushes to their feet. The nasal congestion is due to dilation of vessels in the nasal mucosa. One phenomenon associated with prazosin is known as the "first dose response", in which the side effects of the drug, especially orthostatic hypotension, are especially pronounced after the first dose. Another Common Side effect of Prazosin(And Doxazosin) is Priapism.[3][4].
This medication has shown to be effective in treating severe nightmares in children, associated with PTSD symptoms.